PCR268 The Impact of Radiotherapy Non-Compliance on the Recurrence and Mortality of Breast Cancer Patients: A Systematic Review

Autor: Suryanegara, FDA, Icanervilia, AV, Dewi, GK, Setiawan, D, de Jong, L, Postma, MJ

Publikováno v: In Value in Health December 2022 25(12) Supplement:S442-S442

A Systematic Review of Health-Related Quality of Life in Women with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab.

Autor: Khoirunnisa SM; Department of Health Sciences, University Medical Center Groningen, University of Groningen, 9713 GZ, Groningen, The Netherlands. s.m.khoirunnisa@rug.nl.; Science in Healthy Aging and healthcaRE (SHARE) Institute, University of Groningen, 9713 GZ, Groningen, The Netherlands. s.m.khoirunnisa@rug.nl.; Department of Pharmacy, Institut Teknologi Sumatera, Lampung Selatan, 35365, Indonesia. s.m.khoirunnisa@rug.nl., Suryanegara FDA; Department of Health Sciences, University Medical Center Groningen, University of Groningen, 9713 GZ, Groningen, The Netherlands.; Science in Healthy Aging and healthcaRE (SHARE) Institute, University of Groningen, 9713 GZ, Groningen, The Netherlands.; Department of Pharmacy, Universitas Islam Indonesia, Yogyakarta, 55584, Indonesia., de Jong LA; Department of Health Sciences, University Medical Center Groningen, University of Groningen, 9713 GZ, Groningen, The Netherlands.; Science in Healthy Aging and healthcaRE (SHARE) Institute, University of Groningen, 9713 GZ, Groningen, The Netherlands., Setiawan D; Faculty of Pharmacy, Universitas Muhammadiyah Purwokerto, Banyumas, 53182, Indonesia.; Centre for Health Economic Studies, Universitas Muhammadiyah Purwokerto, Banyumas, 53182, Indonesia., Postma MJ; Department of Health Sciences, University Medical Center Groningen, University of Groningen, 9713 GZ, Groningen, The Netherlands.; Science in Healthy Aging and healthcaRE (SHARE) Institute, University of Groningen, 9713 GZ, Groningen, The Netherlands.; Department of Economics, Econometrics and Finance, Faculty of Economics and Business, University of Groningen, 9713 GZ, Groningen, The Netherlands.; Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Airlangga, Surabaya, 60115, Indonesia.; Centre of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, 45363, Indonesia.

Publikováno v: PharmacoEconomics - open [Pharmacoecon Open] 2024 Jul; Vol. 8 (4), pp. 511-524. Date of Electronic Publication: 2024 Mar 15.

Economic evaluation of trastuzumab in HER2-positive early breast cancer in Indonesia: A cost-effectiveness analysis.

Autor: Khoirunnisa SM; Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Pharmacy, Institut Teknologi Sumatera, Lampung Selatan, Indonesia., Suryanegara FDA; Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Pharmacy, Universitas Islam Indonesia, Yogyakarta, Indonesia., Setiawan D; Faculty of Pharmacy, Universitas Muhammadiyah Purwokerto, Banyumas, Indonesia.; Centre for Health Economic Studies, Universitas Muhammadiyah Purwokerto, Banyumas, Indonesia., Postma MJ; Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Faculty of Economics & Business, Department of Economics, Econometrics and Finance, University of Groningen, Groningen, The Netherlands.; Faculty of Medicine, Department of Pharmacology and Therapy, Universitas Airlangga, Surabaya, Indonesia.; Centre of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia., de Jong LA; Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Publikováno v: PloS one [PLoS One] 2024 May 24; Vol. 19 (5), pp. e0304483. Date of Electronic Publication: 2024 May 24 (Print Publication: 2024).

Health-related quality of life in Her2-positive early breast cancer woman using trastuzumab: A systematic review and meta-analysis.

Autor: Khoirunnisa SM; Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.; Department of Pharmacy, Institut Teknologi Sumatera, Lampung Selatan, Indonesia., Suryanegara FDA; Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.; Department of Pharmacy, Universitas Islam Indonesia, Yogyakarta, Indonesia., Setiawan D; Faculty of Pharmacy, Universitas Muhammadiyah Purwokerto, Banyumas, Indonesia.; Center for Health Economic Studies, Universitas Muhammadiyah Purwokerto, Banyumas, Indonesia., Postma MJ; Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.; Department of Economics, Econometrics and Finance, University of Groningen, Groningen, Netherlands.; Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.; Centre of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2023 Apr 14; Vol. 14, pp. 1090326. Date of Electronic Publication: 2023 Apr 14 (Print Publication: 2023).